Apjohn Ventures
Early-stage venture capital fund investing in life sciences companies, primarily in the U.S. Midwest. Provides equity financing from seed through Series rounds, deal syndication, technical and clinical due diligence, board-level and operational support, and access to advisors with corporate finance and industry operational experience to advance portfolio companies toward exits (M&A or IPO).
Apjohn Ventures
Kalamazoo, Michigan, United States, North America
Services
Early-stage equity investments
Provides equity financing to life sciences companies (seed through Series rounds) and co-invests with other investors.
Due diligence and advisory services
Technical, clinical and commercial due diligence and post-investment advisory using scientific advisors, fund partners, and domain experts.
Early-stage equity investments
Provides equity financing to life sciences companies (seed through Series rounds) and co-invests with other investors.
Due diligence and advisory services
Technical, clinical and commercial due diligence and post-investment advisory using scientific advisors, fund partners, and domain experts.
Expertise Areas
- Early-stage venture investing in life sciences
- Scientific and technical due diligence
- Clinical development strategy
- Regulatory advisory and readiness
Key Technologies
- Oligonucleotide therapeutics
- Liposomal nanoparticle delivery systems
- Enzyme replacement therapies
- Drug-eluting stent delivery and bioabsorbable carriers